CAS 749863-30-7 | CAROM-007 : Carotegrast methyl
(World's Largest Pharmaceutical Supplier)

CAS 749863-30-7 is a chemical compound with the molecular formula C23H27N5O2. It is also known as Linagliptin, which is a medication used to treat type 2 diabetes.

Linagliptin works by blocking an enzyme called dipeptidyl peptidase-4 (DPP-4), which breaks down incretin hormones that stimulate insulin release. By inhibiting this enzyme, Linagliptin increases insulin secretion and lowers blood sugar levels in people with type 2 diabetes.

Linagliptin can be taken orally once daily, either alone or in combination with other anti-diabetic medications. It has been shown to be effective in reducing hemoglobin A1c levels, a measure of average blood glucose levels over time.

However, like all medications, Linagliptin can cause side effects such as headache, nasopharyngitis, and urinary tract infections. In rare cases, it may also cause more serious side effects such as pancreatitis or hypersensitivity reactions.

It is important to note that Linagliptin should only be used under the guidance of a healthcare professional and in accordance with its prescribed dosage. It may not be suitable for all patients, particularly those with certain medical conditions such as severe renal impairment, and regular monitoring is necessary to ensure its effectiveness and safety.

In summary, CAS 749863-30-7 is a chemical compound with medical uses as a medication for type 2 diabetes. It is effective in lowering blood sugar levels, but should be used with caution and under the guidance of a healthcare professional due to potential side effects.